New clinical CYP3A4 and CYP3A5 genotyping assay recommendations medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization's continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.
E-Mail
ROCKVILLE, Md. - Jan. 26, 2021 - The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization s continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks. Committee members will share expertise and provide recommendations to key stakeholders, including the incoming Biden administration, to help address the many challenges facing healthcare providers and ensure more Americans have timely access to high-quality testing. Timely diagnostic testing is foundational to an effective response to any emerging communicable disease. AMP members have been on the frontlines of this pandemic and have been responsible for managing the ever-increasing demand for testing despite numerous regulatory, reimbursement, supply-chain, logistical,